About Medical Oncology Associates - SD
Clinical Trials at Medical Oncology Associates - SD
During the past decade, Medical Oncology Associates - SD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medical Oncology Associates - SD" #1 sponsor was "Pfizer" with 5 trials, followed by "Telik" with 3 trials
sponsored, "Dendreon" with 2 trials sponsored, "Favrille" with 2 trials sponsored and "Active Biotech AB"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Associates - SD"
#1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Medical Oncology Associates - SD
According to Clinical.Site data, the most researched conditions in "Medical Oncology Associates - SD" are
"Prostate Cancer" (3 trials), "Ovarian Neoplasms" (2 trials), "Advanced Prostate Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials) and "Castration-resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Medical Oncology Associates - SD" in a lesser frequency.
Clinical Trials Intervention Types at Medical Oncology Associates - SD
Most popular intervention types in "Medical Oncology Associates - SD" are "Drug" (10 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Enzalutamide" (2 trials), "sipuleucel-T" (2 trials), "ABR-215050, tasquinimod" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medical Oncology Associates - SD
The vast majority of trials in "Medical Oncology Associates - SD" are
7 trials for "Male" genders, 4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Medical Oncology Associates - SD
Currently, there are NaN active trials in "Medical Oncology Associates - SD".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Medical Oncology Associates - SD,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical Oncology Associates - SD, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".